Enrotril Oral Antibacterial Solution
Active Constituent: 25mg/ml ENROFLOXACIN
Indications For the treatment of diseases caused by susceptible bacterial pathogens in dogs and cats
Primary indications for use in the dog and cat are: Urinary tract infections including infections with E.coli, Proteus spp., Klebsiella spp, Pseudomonas aeruginosa, Staph spp and Group D Streptococcus. Respiratory infections, including infections with E.coli, Streptococcus Spp, Pasteurella spp, Klebsiella spp, Pseudomonas spp, Bordetella bronchiseptica and Staphylococcus spp. Deep pyodermas caused by Staph. Intermedius including those infected with secondary invaders. Wounds, abscesses and discharging sinuses. Deep pyodermas, osteomyelitis and Gram negative septicaemias. Enrotril Oral Solution is useful for treating serious antibiotic resistant infections of the respiratory tract or genito-urinary system, particularly chronic urinary tract infections in cats.
Directions for use: The dose of Enrotril in dogs and cats is 5mg/kg per day equivalent to: 1ml Oral Solution per 5kg bodyweight. Treat for 5 to 10 days.
Restraints DO NOT USE in food producing species of animals. Recommended for use only in companion animals where culture and sensitivity testing indicate no suitable alternative. Contraindications Not for use in dogs less than one year of age, or cats less than 12 weeks of age. Disposal: Dispose of empty packaging by wrapping with paper and putting in garbage.
Storage: Store below 30?C (Room Temperature)
Registered pursuant to the ACVM Act 1997 No. A10228. See www.nzfsa.govt.nz/acvm/ for registration conditions. Prescription Animal Remedy (P.A.R) Class 1, for use only under the authority or prescription of a veterinarian.
Registered and distributed by: Ethical Agents Ltd 54 Hobill Ave Wiri Ph 09 262 1388 firstname.lastname@example.org www.ethicalagents.co.nz
Manufactured by: Troy Pty Ltd Australia